Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

The FDA has cleared the Visby Medical Women's Sexual Health Test for use at home to test for chlamydia, gonorrhea, and ...

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

The prevalence of neurologic manifestations of syphilis reported among patients with early- and late-stage disease increased between 2019 and 2022.

Governors in Arkansas and Indiana are asking the federal government for permission to ban soda and candy purchases with food stamps.

According to a recent survey, the inability to pay for health care has reached its highest point in the United States.

The WHO forged a draft agreement seeking to strengthen global collaboration on future pandemic prevention, preparedness, and response.

Hospitalization risk for severe mpox disease was significantly higher in patients with vs without HIV coinfection.

The US FDA announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.

Federal cuts to funding could “decimate” medical research in the United States, delaying cures and costing countless lives.

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).